Pfizer seeks “expedited” approval for Aussie kids

Thursday, 14 October 2021

Good news:

Pfizer Inc. will make an expedited application to Australia’s medical regulator for its Covid-19 vaccine to be considered for use in children aged five to 11, Health Minister Greg Hunt said.

The company is expected to submit data on its vaccine to the Therapeutic Goods Administration within weeks, Hunt said at a press conference on Thursday.

We should be doing this before the kids go back to school.

Obviously.

About the author

David Llewellyn-Smith is Chief Strategist at the MB Fund and MB Super. David is the founding publisher and editor of MacroBusiness and was the founding publisher and global economy editor of The Diplomat, the Asia Pacific’s leading geo-politics and economics portal. He is also a former gold trader and economic commentator at The Sydney Morning Herald, The Age, the ABC and Business Spectator. He is the co-author of The Great Crash of 2008 with Ross Garnaut and was the editor of the second Garnaut Climate Change Review.